|
1
|
Massic MJ: Prevalence of depression in
patients with cancer. J Natl Cancer Inst Monogr. 57–71. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bailey RK, Geyen DJ, Scott-Gurnell K,
Hipolito MM, Bailey TA and Beal JM: Understanding and treating
depression among cancer patients. Int J Gynecol Cancer. 15:203–208.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bodurka-Bevers D, Basen-engquist K,
Carmack CL, Fitzgerald MA, Wolf JK, de Moor C and Gershenson DM:
Depression, anxiety, and quality of life in patients with
epithelial ovarian cancer. Gynecol Oncol. 78:302–308. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Price MA, Butow PN, Costa DS, King MT,
Aldridge LJ, Fardell JE, DeFazio A and Webb PM: Australian Ovarian
Cancer Study Group; Australian Ovarian Cancer Study Group Quality
of Life Study Investigators: Prevalence and predictors of anxiety
and depression in women with invasive ovarian cancer and their
caregivers. Med J Aust. 193 5 Suppl:S52–S57. 2010.PubMed/NCBI
|
|
5
|
Yang Y, Cui Y, Sang K, Dong Y, Ni Z, Ma S
and Hu H: Ketamine blocks bursting in the lateral habenula to
rapidly relieve depression. Nature. 554:317–322. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cui Y, Yang Y, Ni Z, Dong Y, Cai G,
Foncelle A, Ma S, Sang K, Tang S, Li Y, et al: Astroglial Kir4.1 in
the lateral habenula drives neuronal bursts in depression. Nature.
554:323–327. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lovejoy NC and Matties M: Pharmacokinetics
and pharmacodynamics of mood-altering drugs in patients with
cancer. Cancer Nurs. 19:407–418. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dwivedi Y, Rizavi HS, Roberts RC, Conley
RC, Tamminga CA and Pandey GN: Reduced activation and expression of
ERK1/2 MAP kinase in the post-mortem brain of depressed suicide
subjects. J Neurochem. 77:916–928. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nature Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
12
|
da Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data of 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Plattner F, Hayashi K, Hernández A,
Benavides DR, Tassin TC, Tan C, Day J, Fina MW, Yuen EY, Yan Z, et
al: The role of ventral striatal cAMP signaling in stress-induced
behaviors. Nat Neurosci. 18:1094–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong KK: Recent developments in
anti-cancer agents targeting the Ras/Raf/MEK/ERK pathway. Recent
Pat Anticancer Drug Discov. 4:28–35. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dwivedi Y, Rizavi HS, Roberts RC, Conley
RC, Tamminga CA and Pandey GN: Reduced activation and expression of
ERK1/2 MAP kinase in the post-mortem brain of depressed suicide
subjects. J Neurochem. 77:916–928. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taliaz D, Stall N, Dar DE and Zangen A:
Knockdown of brain-derived neurotrophic factor in specific brain
sites precipitates behaviors associated with depression and reduces
neurogenesis. Mol Psychiatry. 15:80–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding L, Zhang C, Masood A, Li J, Sun J,
Nadeem A, Zhang HT, O'Donnell JM and Xu Y: Protective effects of
phosphodiesterase 2 inhibitor on depression- and anxiety-like
behaviors: involvement of antioxidant and anti-apoptotic mechanism.
Behav Brain Res. 268:150–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu M, Chen Y, Jiang L, Li Y, Lan T, Wang Y
and Qian H: Type II cGMP-dependent protein kinase inhibits
epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt
signal transduction in gastric cancer cell. Oncol Lett.
6:1723–1728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tao Y, Gu YJ, Cao ZH, Bian XJ, Lan T, Sang
JR, Jiang L, Wang Y, Qian H and Chen YC: Endogenous cGMP-dependent
protein kinase reverses EGF-induced MAPK/ERK signal transduction
through phosphorylation of VASP at Ser239. Oncol Lett. 4:1104–1108.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karami-Tehrani F, Fallahian F and Atri M:
Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and
PKGII in malignant and benign breast tumors. Tumor Biol.
33:1927–1932. 2012. View Article : Google Scholar
|
|
22
|
Li H, Zeng J and Shen K: PI3K/AKT/mTOR
signaling pathway as a therapeutic target for ovarian cancer. Arch
Gynecol Obstet. 290:1067–1078. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polyakova M, Stuke K, Schuemberg K,
Mueller K, Schoenknecht P and Schroeter ML: BDNF as a biomarker for
successful treatment of mood disorders: A systematic &
quantitative meta-analysis. J Affect Disord. 174:432–440. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bachis A, Mallei A, Cruz MI, Wellstein A
and Mocchetti I: Chronic antidepressant treatments increase basic
fibroblast growth factor and fibroblast growth factor-binding
protein in neurons. Neropharmacology. 55:1114–1120. 2008.
View Article : Google Scholar
|
|
25
|
Jiao J, Zhao X, Liang Y, Tang D and Pan C:
FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC)
metastasis through epithelial-mesenchymal transition (EMT). Biochem
Biophys Res Commun. 466:327–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Renaud F, Desset S, Oliver L,
Gimenez-Gallego G, Van Obberghen E, Courtois Y and Laurent M: The
neurotrophic activity of fibroblast growth factor 1 (FGF1) depends
on endogenous FGF1 expression and is independent of the
mitogen-activated kinase cascade pathway. J Biol Chem.
271:2801–2811. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cohen MM Jr: The AKT genes and their roles
in various disorders. Am J Med Genet A. 161A:2931–2937. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Madhunapantula SV and Robertson GP:
Targeting protein kinase-b3 (akt3) signaling in melanoma. Expert
Opin Ther Targets. 21:273–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yeganeh PN, Richardson C,
Bahrani-Mostafavi Z, Tait DL and Mostafavi MT: Dysregulation of
AKT3 along with a small panel of mRNAs stratifies high-grade serous
ovarian cancer from both normal epithelia and benign tumor tissue.
Genes Cancer. 8:784–798. 2017.PubMed/NCBI
|
|
30
|
Poduri A, Evrony GD, Cai X, Elhosary PC,
Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, et
al: Somatic activation of AKT3 causes hemispheric developmental
brain malformations. Neuron. 74:41–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hirao K, Hata Y, Ide N, Takeuchi M, Irie
M, Yao I, Deguchi M, Toyoda A, Sudhof TC and Takai Y: A novel
multiple PDZ domain-containing molecule interacting with
N-methyl-D-aspartate receptors and neuronal cell adhesion proteins.
J Biol Chem. 273:21105–21110. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirao K, Hata Y, Yao I, Deguchi M, Kawabe
H, Mizoguchi A and Takai Y: Three isoforms of synaptic scaffolding
molecule and their characterization. Multimerization between the
isoforms and their interaction with N-methyl-D-aspartate receptors
and SAP90/PSD-95-associated protein. J Bol Chem. 275:2966–2972.
2000. View Article : Google Scholar
|
|
33
|
Hu Y, Li Z, Guo L, Wang L, Zhang L, Cai X,
Zhao H and Zha X: MAGI-2 Inhibits cell migration and proliferation
via PTEN in human hepatocarcinoma cells. Arch Biochem Biophys.
467:1–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
